191 related articles for article (PubMed ID: 30980596)
1. Biochemical pathways mediated by KLK6 protease in breast cancer.
Pampalakis G; Zingkou E; Sidiropoulos KG; Diamandis EP; Zoumpourlis V; Yousef GM; Sotiropoulou G
Mol Oncol; 2019 Nov; 13(11):2329-2343. PubMed ID: 30980596
[TBL] [Abstract][Full Text] [Related]
2. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.
Sidiropoulos KG; Ding Q; Pampalakis G; White NM; Boulos P; Sotiropoulou G; Yousef GM
Mol Oncol; 2016 Aug; 10(7):993-1007. PubMed ID: 27093921
[TBL] [Abstract][Full Text] [Related]
3. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G
Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398
[TBL] [Abstract][Full Text] [Related]
6. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
[TBL] [Abstract][Full Text] [Related]
7. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer.
Pampalakis G; Sotiropoulou G
Biol Chem; 2006 Jun; 387(6):773-82. PubMed ID: 16800739
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
12. A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering.
Sananes A; Cohen I; Shahar A; Hockla A; De Vita E; Miller AK; Radisky ES; Papo N
J Biol Chem; 2018 Aug; 293(33):12663-12680. PubMed ID: 29934309
[TBL] [Abstract][Full Text] [Related]
13. [Expression of KLK6 protein and mRNA in primary breast cancer and its clinical significance].
Wang SM; Mao J; Li B; Wu W; Tang LL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1087-9. PubMed ID: 18992199
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
16. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.
Kim JJ; Kim JT; Yoon HR; Kang MA; Kim JH; Lee YH; Kim JW; Lee SJ; Song EY; Myung PK; Lee HG
Tumour Biol; 2012 Jun; 33(3):731-8. PubMed ID: 22373580
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
18. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
20. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]